Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-01-18 00:00:00 ET · period of report 2023-01-17 · accession 0000899243-23-002074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-18 | 2023-01-17 | TMDX | Carey John F | VP of Ops | M - OptEx | $38.46 | +1,410 | 15.5K | +10% | +$54.2K |
| DM | 2023-01-18 | 2023-01-17 | TMDX | Carey John F | VP of Ops | S - Sale+OE | $62.71 | -1,410 | 15.5K | -8% | -$88.4K |
| D | 2023-01-18 | 2023-01-17 | TMDX | Carey John F | VP of Ops | M - OptEx | $0.00 | -1,410 | 13.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-17 | M | A | 1,410 | $38.46 | 15,530 | D | — | — | (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-01-17 | S | D | 114 | $64.30 | 14,120 | D | — | — | (F6) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.19 to $64.52, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2023-01-17 | S | D | 449 | $63.70 | 14,234 | D | — | — | (F5) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.19 to $64.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2023-01-17 | S | D | 338 | $62.48 | 14,683 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.18 to $63.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2023-01-17 | S | D | 446 | $61.77 | 15,021 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.18 to $62.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2023-01-17 | S | D | 63 | $60.72 | 15,467 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.12 to $61.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F7) The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| 7 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | M | D | 1,410 | $0.00 | 13,590 | D | $38.46 · — to 2031-02-24 | 1,410 Common Stock | (F8) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |